Predicta Biosciences, a pioneering precision oncology company, has announced a significant milestone with the successful closure of an oversubscribed $5.2 million seed funding round. Led by The Engine Ventures, this round saw participation from notable investors including Illumina Ventures, Time Boost Capital, the American Cancer Society Bright Edge, and the Oetgen family. The funds raised…
Cardurion Pharmaceuticals, a pioneering biotechnology firm specializing in innovative therapies for cardiovascular diseases, has announced the successful completion of a $260 million Series B financing round. Led by Ascenta Capital and supported by a consortium of esteemed investors including NEA, GV, and Fidelity Management & Research Company, this substantial funding underscores Cardurion’s commitment to advancing…
Bioniq, a trailblazer in AI-driven personalized supplements tailored to individual health needs, has successfully closed a $15 million Series B funding round. Led by prominent European VCs HV Capital and Unbound, this funding underscores Bioniq’s commitment to disrupting the one-size-fits-all approach prevalent in the dietary supplements industry. The company, valued at $75 million post-funding, plans…
Exa, a pioneering AI research lab focused on revolutionizing search capabilities for artificial intelligence, has secured $22 million in seed and Series A funding led by Lightspeed Venture Partners. This investment round also saw participation from NVentures, NVIDIA’s venture capital arm, and Y Combinator, underscoring confidence in Exa’s vision to establish itself as the foundational…
Infinitum, a trailblazer in sustainable technology with its innovative air-core motor systems, has announced a significant boost to its Series E funding with an additional $35 million investment. This extension, led by Marunouchi Innovation Partners and Rice Investment Group, brings the total Series E funding to $220 million. The funding infusion aims to propel Infinitum’s…
Good news for anyone experiencing those pesky eye floaters! PulseMedica, a rising star in the life sciences field, has secured $12 million CAD in funding to revolutionize how we diagnose and treat these vision disruptions. This investment fuels the development of their innovative platform, offering a beacon of hope for millions who struggle with these…
Good news for the pharmaceutical industry! Modicus Prime, a Texas-based innovator, has secured $3.5 million in Series A funding to revolutionize drug manufacturing with their AI-powered quality control solution, mpVision. This investment, led by Silverton Partners, empowers Modicus Prime to tackle a persistent challenge – ensuring consistent quality and eliminating costly errors during production. Traditionally,…
Alvys, a next-generation logistics platform aiming to revolutionize supply chain management, has secured $20.5 million in a Series A funding round. This investment, led by Titanium Ventures with participation from Picus Capital and existing investors RTP and Bonfire, fuels Alvys’ mission to become the go-to platform for logistics and supply chain operations. The funding windfall…
Velentium, a Houston-based engineering leader in medical device design and manufacturing, has secured a significant $15 million investment from Trinity Capital Inc. This strategic partnership fuels Velentium’s mission to deliver innovative and life-saving medical technologies. Velentium’s expertise spans across the entire medical device lifecycle, from concept to production. Their team offers a unique blend of…
Neuspera Medical, a company pioneering a discreet and minimally invasive treatment for overactive bladder (OAB), has secured $23 million in Series D financing. This significant investment round, led by Vertex Ventures HC and Treo Ventures, will propel Neuspera’s Neuspera System through U.S. Food and Drug Administration (FDA) premarket approval (PMA) and towards commercialization. OAB, a…
